** Shares of medical device maker ECOR.O up as much as
2.06% at 60 cents
** Co enters into deal with Teijin to license certain
exclusive rights to its non-invasive vagus nerve stimulation
(nVNS) technology for commercialization in Japan for headache
disorders urn:newsml:reuters.com:*:nGNXbzJx75
** Under the agreement, ElectroCore will receive a
non-refundable, upfront payment for the licenses and rights
granted to the Japan-based conglomerate
** Stock up ~2% YTD, as of last close
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com; Twitter: https://twitter.com/rithika_krishna;))